Low back pain is a major cause for disability and is closely linked to intervertebral disc degeneration. Mechanical and biological dysfunction of the nucleus pulposus in the disc has been found to initiate intradiscal degenerative processes. Replacing or enriching the diseased nucleus pulposus with an injectable, stem cell-laden biomaterial that mimics its material properties can provide a minimally invasive strategy for biological and structural repair of the tissue. In this study, injectable, in situ-gelling carboxymethylcellulose hydrogels were developed for nucleus pulposus tissue engineering using encapsulated human marrow-derived mesenchymal stromal cells (hMSCs). With the goal of obtaining robust extracellular matrix deposition and faster construct maturation, two cell-seeding densities, 20 Â 10 6 cells/ml and 40 Â 10 6 cells/ml, were examined. The constructs were fabricated using a redox initiation system to yield covalently crosslinked, cell-seeded hydrogels via radical polymerization. Chondrogenic culture of the hydrogels over 35 days exhibited high cell viability along with deposition of proteoglycan and collagen-rich extracellular matrix, and mechanical and swelling properties similar to native human nucleus pulposus. Further, the matrix production and distribution in the carboxymethylcellulose hydrogels was found to be strongly influenced by hMSC-seeding density, with the lower cellseeding density yielding a more favorable nucleus pulposus-specific matrix phenotype, while the rate of construct maturation was less dependent on the cell-seeding density. These findings are the first to demonstrate the utility of redox-polymerized carboxymethylcellulose hydrogels as hMSC carriers for potential minimally invasive treatment strategies for nucleus pulposus replacement.
Introduction
Intervertebral disc (IVD) disease is the major cause of low back pain, a debilitating condition affecting over 630 million people worldwide with a high lifetime prevalence. 1 Degeneration of the IVD is strongly associated with low back pain and is characterized by a distinct loss of extracellular matrix (ECM) molecules from the inner, nucleus pulposus (NP) tissue of the IVD. 2 In a healthy state, the NP has a matrix rich in waterabsorbing proteoglycans and associated collagens that allow the tissue to withstand compressive loads and maintain disc height, while the outer lamellar, collagenous annulus fibrosus (AF) maintains the shape of the IVD and withstands tensile hoop stresses. 3 Aging, disease or trauma can give rise to a homeostatic imbalance and increase catabolic activity in the tissue.
This results in the degradation of ECM molecules and their subsequent loss from the IVD, 4 leading to mechanical failure. In pathologies or traumatic injuries leading to disc herniation, the AF structural integrity is compromised, allowing NP tissue to extrude through the annulus. 5 The resulting impingement of NP tissue on nerve roots and the associated increase in inflammatory cytokine production have been implicated in spinal nociception. [6] [7] [8] The most common surgical treatment for this condition is discectomy or nucleotomy, which involves removal of herniated NP material. Unfortunately, this treatment has several drawbacks (i.e., reduced disc height, altered disc biomechanics) and often necessitates a second surgical procedure, with many patients reporting recurrent pain. [9] [10] [11] [12] Recent efforts to restore disc function following early stage IVD degeneration or injury have focused on developing NP replacement materials from an array of natural or synthetic sources. 13, 14 Devices composed of preformed polymers or metallic components remain largely investigational due to invasive procedures required for implantation and clinical failure resulting from device migration and extrusion from the herniation site. [15] [16] [17] Injectable hydrogel materials provide the benefits of minimally invasive administration coupled with the ability to fill the entire void space and conform to the internal margins of the tissue deficit, improving retention and mechanical load distribution within the IVD. Photocrosslinking methods have been employed to form in situ gelling NP replacement scaffolds via radical polymerization. These photocrosslinked gels support NP cell differentiation and approximate the mechanical properties of the native tissue. 18, 19 Still, the reliance upon light exposure to cure these injectable polymers poses a challenge in the confined intradiscal space. Alternative approaches based on other crosslinking chemistries such as the Schiff base reaction or Michael-type addition obviate the need for light exposure. 20, 21 Nevertheless, these methods often require higher concentrations of prepolymer material or extended curing times to achieve complete gelation, both of which present hurdles to clinical translation. [22] [23] [24] [25] More rapid gelation has been achieved using reduction/oxidation (redox)-initiated, free radical polymerization to engineer NP replacement materials. 26, 27 However, such strategies are often not amenable to cell encapsulation given the inherent toxicity of the initiators or generated radicals. 28 Therefore, there is a need for hydrogels that undergo in situ gelation, which also possess appropriate functional mechanical properties, curing times, and cytocompatibility to be used in conjunction with current surgical treatments (i.e., discectomy).
Hydrogels composed of a variety of natural materials have been widely investigated for NP tissue engineering strategies. 29 For example, hyaluronic acid and collagen-based scaffolds have been explored as NP replacements, exhibiting good biocompatibility and the capacity to direct stem cell differentiation towards a chondrocyte-like phenotype. 30, 31 However, these constructs are susceptible to rapid enzymatic degradation in vivo, particularly in injured discs. Carboxymethylcellulose (CMC) is a biocompatible, polyanionic, water-soluble, FDA-approved cellulose derivative that is readily available in high purity forms at affordable costs. 32 The deprotonation of carboxylic groups in CMC at physiologic pH creates a negatively charged, water-absorbing polymer network akin to the glycosaminoglycan (GAG)-rich ECM found in native NP. In addition, modification of the CMC polymer backbone with methacrylate groups enables crosslinking between the polymer chains by free radical polymerization, creating a mechanically stable network. 33, 34 While the resulting interchain ester linkages are hydrolyzable, the cellulose-based polymer chains are resistant to enzymatic degradation in humans, allowing for controlled degradation of the hydrogel over time. 34, 35 Injectable hydrogels of methacrylated CMC with the ability to gel in situ may be created by employing a water-soluble redox initiation system consisting of ammonium persulfate (APS) and tetramethylethylenediamine (TEMED). Although redox-initiated crosslinking systems are often cytotoxic, APS and TEMED have been utilized previously in cell-laden hydrogel constructs with limited toxicity when used at low concentrations (<25 mM). [36] [37] [38] Such systems may prove effective for fabricating CMCbased gels to reliably deliver cells and restore function of degenerated or injured IVDs. 39 Several preclinical studies have attempted cellular strategies for IVD regeneration using a variety of autologous and allogeneic cell sources ranging from NP cells and chondrocytes to adipose and bone marrow-derived mesenchymal stem cells (MSCs). 39 The injection or transplantation of these healthy cells into a degenerated or herniated disc space has shown improved outcomes as demonstrated by the maintenance of disc height and hydration, and upregulation of native matrix molecules. 40 More recently, preclinical studies and clinical trials utilizing autologous or allogeneic MSCs for cell-based disc repair have shown substantial reduction in discogenic back pain, 1, 41, 42 particularly at higher cell densities. [43] [44] [45] Nevertheless, many investigations have reported that leakage of transplanted cells into the surrounding tissue induces undesired results, such as osteophyte formation. 46, 47 The use of an injectable carrier material could prevent such leakage from the injured NP.
Thus, the objective of this study was to engineer an injectable, redox-polymerized CMC hydrogel that supports human marrow-derived mesenchymal stromal cells (hMSCs) viability and differentiation towards an NP-like phenotype, as determined by characteristic biomacromolecular composition (i.e., sulfated proteoglycans and collagen II). We hypothesized that tissueengineered CMC constructs with higher cell-seeding density would mature faster and result in greater ECM elaboration and mechanical properties.
Materials and methods

Macromer synthesis
Methacrylation of 250 kDa CMC (Sigma-Aldrich) was performed based on a previous protocol. 34, 48 Briefly, 1% (w/v) solution of 250 kDa CMC was reacted with a 20-fold excess of methacrylic anhydride (Sigma-Aldrich) in sterile water at 4 C and at pH 8.5 over 24 h. To remove excess, unreacted methacrylic anhydride, the CMC solution was dialyzed against sterile water for over 96 h and the purified solution was lyophilized to obtain a solid product. The degree of methacrylation was confirmed using 
Gelation characterization
Rheology. Rheological analysis was performed to characterize gelation kinetics of CMC hydrogel formation. An AR2000ex (TA Instruments) rheometer equipped with a cone and plate geometry (2 , 20 mm) was used to record measurements at 37 C. Optimal test parameters (1% strain at 1 Hz frequency) were selected via strain and frequency sweep measurements on the base polymer solution (2% (w/v)) in Dulbecco's Phosphate Buffered Saline (DPBS) and were obtained from the linear viscoelastic region where G 0 and G 00 are independent of frequency and strain. 49 Further, gelation characteristics were determined from 2% (w/v) CMC solutions mixed with APS and TEMED in separate barrels of a dual-barrel syringe, both at a final concentration of 10 mM (n ¼ 3). Previous studies have shown that a minimum initiator concentration of 10 mM was required to obtain stable cellulosic hydrogels. 35, 50 Gelation onset was determined by oscillation measurement (time sweep) and defined as the crossover of the storage (G 0 ) and loss moduli (G 00 ) with respect to time. The first time point at which at least four consecutive G 0 values exhibited less than 1% change was designated as the gelation completion time. 35, 50, 51 The complex modulus, G*, was obtained at gelation completion while the complex viscosity, g, was measured immediately after injection.
Preliminary evaluation of in situ gelation. Using a dualbarrel syringe, 500 ll of the CMC hydrogel solutions and redox initiators APS and TEMED at 10 mM were injected subcutaneously into the dorsa of freshly euthanized Wistar rats in accordance with a protocol exemption approved by The City College of New York Institutional Animal Care and Use Committee. Trypan blue was mixed with the pre-polymerized solution for visualization. The subcutaneous tissue was dissected and examined for the presence of a solid hydrogel 30 min after injection. Gross images were obtained of the in situ formed hydrogels.
Primary cell isolation
hMSCs were isolated from adult human bone marrow (AllCells, Emeryville, CA) via enriched density gradient centrifugation as previously described. [52] [53] [54] Briefly, a hMSC Enrichment Cocktail (StemCell Technologies, Vancouver, BC, Canada) was added to the bone marrow and incubated for 20 min to crosslink unwanted cells and red blood cells via tetrameric antibody complexes. This mixture was layered over a volume of Ficoll-Paque PLUS (StemCell Technologies) 55 and centrifuged for 25 min at 1200 r/min to separate the enriched cell layer of hMSCs. The enriched cell layer was extracted from the solution at the Ficoll-Paque PLUS:plasma interface. These primary cells were transferred onto tissue culture flasks and cultured in hMSC growth medium containing low-glucose Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA), 10% fetal bovine serum (Hyclone, Logan, UT), 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen) and were designated as passage 0. Cells were subcultured four times to obtain the necessary number of cells.
Hydrogel preparation and culture
Passage 4 hMSCs were encapsulated in redoxpolymerized CMC hydrogels at densities of 20 Â 10 6 cells/ml (20 M) and 40 Â 10 6 cells/ml (40 M). Briefly, cells were suspended in the polymer solution along with APS and TEMED in separate barrels of a dual-barrel syringe, both at a final concentration of 10 mM. The polymer and redox initiators were sterilized with UV light and syringe filters, respectively. The solutions were mixed and were allowed to set for 15 min in a custom casting device to obtain covalently crosslinked hydrogels of 5 mm diameter and 2 mm thickness at a final macromer concentration of 2% (w/v). All hydrogels were cultured in vitro in hMSC growth medium overnight followed by culture in serum-free, chemically defined medium 18 supplemented with 10 ng/ml rhTGFb3 (R&D Systems). Negative control gels cultured without growth factors were not included in this study as previous studies using hMSC-seeded photocrosslinked CMC hydrogels demonstrated minimal matrix production in the absence of rhTGF-b3. 52, 56 Cell viability Both 20 M and 40 M hydrogel constructs were examined for cytotoxicity over the 35-day culture period. Each hydrogel construct isolated at different time points was cut in two; one half was used to measure cell proliferation and the other half was used to quantify cell viability. Total DNA content was measured to monitor cell proliferation in the constructs on days 7, 21 and 35 via the PicoGreen assay (Molecular Probes, Eugene, OR) (n ¼ 4-5) and calf thymus DNA (Sigma-Aldrich) was used to create a standard curve. Hydrogels were lyophilized, homogenized and digested with pepsin 18, 52 and the samples were analyzed with a BioTek Instruments microplate reader (Synergy 4, Winooski, VT) at an excitation of 480 nm and emission of 520 nm. Cell viability was quantified via the MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay kit (ATCC, Manassas, VA) on days 1, 7, 21 and 35. The gels were incubated in 1 ml of growth medium along with 100 ll of yellow tetrazolium MTT for 4 h in the dark at 37 C and 5% CO 2 (n ¼ 3). Post incubation, the hydrogels were homogenized, and formazan crystals were extracted with MTT detergent solution in the dark for 4 h at room temperature. The absorbance was measured at 570 nm and normalized to the wet weight of the gel. The viability of the cellular constructs was visually assessed with Live/Dead staining (Invitrogen), using calcein AM (green, indicative of live cells) and ethidium homodimer-1 (red, indicative of dead cells) (n ¼ 1-2).
Biochemistry
Cell-laden hydrogel constructs were isolated on days 7, 21 and 35 to measure collagen II (COL II) and total sulfated GAG content. 18, 52 Briefly, the isolated gels were lyophilized and homogenized. The homogenate was digested for 48 h at 4 C with pepsin (Sigma-Aldrich) prepared in 0.05 N acetic acid. Thereafter, the solution was neutralized with 10Â Tris-buffered saline. Total sulfated GAG content in the constructs was measured using the 1,9-dimethylmethylene blue assay (Sigma-Aldrich). The dye was prepared at a pH of 1.5 to minimize the detection of carboxyl group complexes derived from the CMC backbone, and the absorbance was measured at 595 nm. 57 Shark-derived chondroitin-6 sulfate was used as the standard (Sigma-Aldrich). COL II content in the hydrogels was quantified using an indirect enzyme-linked immunosorbent assay with monoclonal antibodies (II-II6B3, Developmental Studies Hybridoma Bank, University of Iowa, Iowa, IA), based on prior protocols. 18, 52 Protein measurements were determined using human COL II standards (Chondrex, Inc., Redmond, WA) at an absorbance of 450 nm. Total sulfated GAG and COL II content were normalized to wet weight of the samples at all time points (n ¼ 4-5). Further, the rates of accumulation for GAG and COL II were calculated as the slope of the normalized content for each ECM component over time.
The ratio between the GAG and COL II values from the above biochemical assays provided GAG:COL II measurements. The GAG:hydroxyproline ratio has been reported as 27:1 in the human NP 58, 59 and can be approximated as a 4:1 GAG:COL II ratio based on the estimated mass ratio of 1:7.5 between hydroxyproline and collagen. 60, 61 Histology and immunohistochemistry Cultured cellular hydrogels isolated on days 7, 21 and 35 were fixed overnight in a buffered zinc formalin solution (Z-Fix, Anatech) and ethylene glycol monoethyl ether (Fischer Scientific) followed by a second dehydration step using 2-propanol for 5 h. The samples were cleared using methyl salicylate (Sigma) for 10 h and infiltrated with paraffin for 6 h (with 3 paraffin solution changes throughout the 6 h). Paraffinembedded samples were sectioned at a thickness of 8 lm using a Thermo Scientific Microm Rotary Microtome (Model HC 325; Walldorf, Germany). 62 Cellular distribution and morphology within the constructs were visualized using hematoxylin and eosin (H&E) staining. 63 Alizarin Red staining was performed to observe calcium deposits indicative of mineralization and 1% Alcian Blue (pH ¼ 1.0) was used to detect sulfated GAGs. Additionally, immunohistochemistry (IHC) based on a previous protocol was performed to assess deposition of specific ECM components in the hydrogels on days 7, 21 and 35.
52 Accordingly, monoclonal antibodies to COL I (Sigma Aldrich), II (Developmental Studies Hybridoma Bank (DSHB)), VI (DSHB) and X (DSHB) (1 lg/ml in 10% horse serum) and chondroitin sulfate proteoglycan (CSPG) (Sigma Aldrich) (1 lg/ml in goat serum) were employed. A peroxidase-based system (Vectastain Elite ABC, Vector Labs, Burlingame, CA) along with the chromogen, 3,3'-diaminobenzidine (Vector Labs), were used to visualize collagen and CSPG localization in the ECM. The stained sections were imaged and captured using the Zeiss Axio Imager Z1 (Carl Zeiss, Inc., Thornwood, NY) optical microscope and AxioVision software (Carl Zeiss, Inc.) (n ¼ 2-3).
Material properties of cell-seeded constructs
Swelling properties. The equilibrium weight swelling ratio (Q w ) of the gels was measured at days 7, 21 and 35 (n ¼ 4-5). 35, 50, 52 The constructs were maintained in DPBS overnight at 37 C and weighed to obtain the wet weights (W s ), after which, the dry weights (W d ) were measured following lyophilization. The following equation was used to calculate Q w
Mechanical testing. Hydrogel constructs were characterized for their mechanical properties under unconfined compression using a custom built-apparatus and a protocol previously described 34, 35, 56 (n ¼ 5-6). Briefly, the test included a creep test followed by a multi-ramp stress relaxation test. The hydrogels underwent a 1 g creep tare load with a ramp velocity of 10 lm/s for 2700 s, until equilibrium (equilibrium criterion: <10 lm change in 10 min). This was followed by a stress relaxation test consisting of three 5% strain ramps adding up to a 15% cumulative strain, with a 2000 s relaxation period between ramps (equilibrium criterion: <0.5 g change in 10 min). Equilibrium strain (e eq ) was calculated as
The peak stress (r pk ) and equilibrium stress (r eq ) were calculated at the third ramp corresponding to 15% strain. The percent relaxation was calculated based on the formula
The equilibrium Young's modulus (E y ) was measured as the average slope of the stress versus strain curves of the 5%, 10% and 15% ramps.
Statistical analysis
A two-way ANOVA with a Tukey's post-hoc test was used to determine the effects of cell-seeding density and time on the material properties, cell viability and biochemical content. Significance was set at p < 0.05. Data represent mean AE SD. A linear regression analysis was performed on pooled data sets to identify the relationship between the primary ECM components, COL II and GAG, and the mechanics of the hydrogels, specifically the E y values (Supplemental Figure S4) .
Results
The CMC polymer was methacrylated to enable redoxinitiated crosslinking at a modification level of 7.5%, which was verified by 1 H-NMR (Supplemental Figure S1 ).
Gelation and injectability characteristics
The gelation properties of acellular CMC solutions were measured via time sweep measurements. The onset of gelation in 2% (w/v) CMC solutions was estimated to occur within 1 min and 30 s (gelation onset occurred prior to rheometer data recording) (Figure 1(a) ). The initial complex viscosity, g, at injection was 0.128 AE 0.024 PaÁs. Gelation completion was measured at 11.55 AE 0.75 min (Figure 1(a) ), while the corresponding complex modulus, G*, was 758.10 AE 116.91 Pa and d was 0.10 AE 0.06 (Figure 1(b) ). In situ gelation characteristics were qualitatively assessed with a subcutaneous injection of the acellular hydrogel formulation into freshly euthanized Wistar rats. Examination of the subcutaneous tissue 30 min after injection revealed stable hydrogels with defined shape and borders (Figure 1(c) and (d) ).
Cell viability and proliferation
hMSC-laden, redox-polymerized CMC hydrogel constructs were fabricated at two seeding densities, 20 Â 
Matrix content and distribution
The GAG content in the hydrogels increased significantly over time in both groups, with the 40 M hydrogels producing significantly more GAG than the 20 M samples on days 21 and 35 (Figure 3(a) c) and (f)) was found in both groups. Similar to COL II, the staining intensity of COL VI in the 40 M gels was less than that in the 20 M hydrogels and was faintest in the center of the gels (data not shown). While the 40 M constructs demonstrated a prominent band of collagens (COL II and COL VI) on the hydrogel periphery, this feature was less noticeable in the GAG staining. Minimal COL I, COL X and Alizarin Red staining was observed in both groups at all time points (Supplemental Figure S3 ).
Material properties of constructs
Swelling properties. The Q w of both 20 M and 40 M groups decreased with time and had significantly lower values at day 35 (21.54 AE 0.80 and 18.18 AE 0.47, respectively) compared to the earlier time points. Although the 40 M hydrogels had a significantly lower Q w on days 7 and 21 with respect to the 20 M group, no significant differences were noted between the 20 M and 40 M groups on day 35 ( Figure 5(d) ).
Mechanical properties. Initial mechanical characterization of the redox-polymerized hydrogels using unconfined compression testing (as described in the section "Mechanical Testing") showed significant increases in the equilibrium Young's modulus (E y ) with increasing macromer concentration (2-4% (w/v)) (Supplemental Figure S2) . The E y of 2% (w/v) CMC hydrogels was within the range shown to be conducive for NP tissue engineering, 34, 56, 64 and thus, was chosen as the formulation for this study.
The equilibrium Young's modulus (E y ) increased with time in both groups and attained significantly higher values at day 35 (17.70 AE 1.96 kPa and 27.94 AE 4.57 kPa, in 20 M and 40 M groups, respectively) compared to all previous time points ( Figure 5(a) ). Similarly, the r pk values rose over time, and at day 35 were significantly greater (11.34 AE 2.02 kPa and 11.89 AE 3.95 kPa, in 20 M and 40 M groups, respectively) than at all earlier time points ( Figure 5(b) ). The day 1 samples from both groups exhibited maximum deformation at equilibrium. The strain values decreased with time, and by day 35, samples in both groups exhibited significantly lower values (0.09 AE 0.04 and 0.054 AE 0.01, in 20 M and 40 M groups, respectively) compared to the day 1 samples of the 20 M group (Figure 5(c) ). The percent relaxation remained relatively constant at 59.59 AE 10.25% over the duration of the study, and the average values for both the 20 M and 40 M group were not significantly different. Further, single variable regression lines demonstrated a strong correlation between both ECM macromolecules (COL II and GAGs) and the E y in both groups (Supplemental Figure S4) .
Discussion
This is the first study to demonstrate the potential of redox-initiated crosslinking to engineer cellulosic hydrogels as hMSC carriers for minimally invasive NP repair. While multiple crosslinking methods have been employed to develop hydrogel systems for this application using natural and synthetic materials, only some have successfully created truly injectable systems with the ability to gel in situ. Photocrosslinking has been a common method used to fabricate hydrogels 52, 65 ; however, poor penetration through tissues limits efficacy of such UV-based photopolymerization techniques in vivo. 66 Injectable hydrogel systems using other crosslinking chemistries including enzymemediated crosslinking, 67, 68 as well as stimuliresponsive materials 69 or those formed by electrostatic interactions, 70 can solidify in situ but may lack stability under physiological conditions, 71 and are limited by longer gelation times (on the order of hours). 72 Redox-initiated polymerization provides a platform for creating covalent crosslinks between methacrylated polymer chains, affording injectability and structural stability 27 while enabling rapid gelation in situ. The use of a hydrogel carrier to deliver MSCs to the NP, a highly pressurized tissue in the IVD, can prevent deleterious leakage of the cells out of the site of application. 46 Moreover, the gel can provide the microenvironment necessary to support the biosynthesis of native matrix molecules critical for the function of the tissue. Cell density is an important determinant of successful chondrogenic differentiation of MSCs and influences key events in chondrogenesis, such as cell condensation and enhanced cell-cell communication. 73, 74 While low cellularity is a characteristic of the adult human NP, the tissue possesses a higher cell density during early development. 75, 76 Research focusing on utilizing MSCs and chondrocytes for cartilage regeneration has highlighted the importance of cell-seeding density in directing construct maturation. Specifically, higher cell densities (>20 Â 10 6 cells/ml) have been shown to give rise to more extensive ECM production, improving construct mechanics critical for the load-bearing capacity of the tissue. [77] [78] [79] [80] [81] Furthermore, recent clinical trials focusing on disc repair have reported a marked reduction in discogenic back pain using MSC injections at higher densities. 1, 41, 42 Thus, cell-seeding density is an important parameter to characterize for a hydrogel carrier, and this study is the first to compare a higher hMSC-seeding density of 40 Â 10 6 cells/ml to the "standard" 20 Â 10 6 cells/ml 52 in redox-polymerized CMC hydrogels. 
Injectability and gelation characteristics
Injectability of in situ-forming hydrogels is governed by gelation and crosslinking mechanisms. Rheological measurements showed that the G* for CMC solutions post gelation (758.10 AE 116.91 Pa) was significantly lower than values reported for human NP tissue (11 kPa). 82 However, these measurements were comparable to other hydrogel systems being developed as injectable scaffolds for NP regeneration (0.8-5 kPa). 67, 83 Injectability of the hydrogel solutions was quantified via complex viscosity measurements and was found to be lower ($0.13 PaÁs) than values reported for commercially available injectable soft tissue filler materials (60-1200 PaÁs) commonly used for soft tissue reconstruction. 84 The solutions also achieved complete gelation within 12 min, which will allow sufficient time for surgical manipulation, and is on the order specified by ISO standard 5833/1-1999 E for injectable materials. The low-phase angle ($0.1 ) of the final hydrogel confirmed its transition from a viscous solution to an elastic solid. 25 The potential application of the redox-polymerized CMC hydrogels as injectable, in situ gelling biomaterials was further strengthened by the formation of stable hydrogels with defined shape and borders following subcutaneous injection of the acellular hydrogel solution into freshly euthanized rats. The applicability of this hydrogel material for NP repair will be evaluated in forthcoming studies with more comprehensive in vivo evaluations in large animal IVDs.
Temporal accumulation and distribution of ECM components
The maintenance of cell viability at both cell-seeding densities in the redox-polymerized CMC hydrogels suggests good cytocompatibility, and additionally, the lack of proliferation over 35 days indicates a shift from a proliferative state to a differentiation phase in the hMSCs in both the 20 M and 40 M hydrogels. 85 As expected, the 40 M group exhibited significantly higher GAG content; however, contrary to our hypothesis, COL II content was significantly higher in the 20 M group. These results were mirrored in the IHC analysis, where COL II and COL VI staining in the 40 M gels were faintest in the gel center, although cell viability was found to be uniform throughout the constructs. Moreover, while the 40 M constructs demonstrated a prominent band of COL II and COL VI on the periphery of the constructs, GAG staining was homogeneous throughout the gels. This suggests that the gel interiors had limited access to growth factors (i.e., TGF-b3 or other soluble factors) specifically necessary for collagen biosynthesis compared to the surface, a result observed in previous studies. 77, 79, 86 The non-uniform production of COL II in the 40 M samples may explain the overall reduction in COL II content relative to the 20 M gels. Similar non-uniformity in matrix accumulation has been reported previously in studies comparing transient versus continuous growth factor supply. 56 These studies underscore the need for continuous availability of growth factors to achieve uniform matrix distribution within the constructs, 80, 81 which could be addressed via dynamic loading of the hydrogels, as would be seen in vivo. Additional assessment of TGF-b transport in these CMC gels at varying seeding densities may be necessary to better understand the mechanism of poor COL II production in the 40 M gels.
Relative contributions of ECM molecules: NP-like matrix phenotype
There is an active debate as to the defining characteristics of NP cells due to morphological similarities between adult NP cells and chondrocytes, along with the overlap in the matrix components of the two cartilaginous tissues. This work focused on ECM composition to delineate the NP-phenotype in the CMC constructs rather than on a specific gene expression profile (i.e., KRT18, 19 and CDH2) 87 as there is no consensus on defining standard NP markers. [88] [89] [90] As a mechanically loaded and extremely hydrated tissue, one of the key features that distinguishes the NP from cartilage is the GAG:COL II ratio which can be approximated as 4:1 in the NP (described in Materials and methods) compared to a ratio of 1:2 in articular cartilage. 90 At day 35, the GAG:COL II ratio was 5:1 for the 20 M hydrogel constructs and 16:1 for the 40 M samples. Thus, between the two groups, the 20 M constructs exhibited relative matrix composition comparable to the native NP.
In addition to examining the relative quantities of constituent molecules, it is also important to assess their absolute quantities with respect to native tissue. By day 35, the absolute GAG content was 25% and 35% of native values (525 lg/mg dry weight) 91 in the 20 M and 40 M hydrogels, respectively. The absolute COL II values were considerably lower at 10% and 4.5% of native COL II values (250 lg/mg dry weight) 91 in the 20 M and 40 M constructs, respectively. Insufficient matrix production is a limitation which has also been documented in other biomaterial systems, 19, 78 although greater GAG and collagen production could potentially be observed over longer culture periods (i.e., >35 days) and with the application of additional biophysical cues, 81 such as dynamic loading. The pericellular matrix formed in cartilaginous and NP tissue plays an important role in regulating hMSC differentiation via mechanotransduction pathways. 64, 92 Among pericellular matrix components, COL VI is a key mechanotransducer interacting with a complex network of collagens and proteoglycans, and controlling cellular deformation under compression. 92 Thus, the presence of COL VI in mature CMC constructs in this study indicates the presence of a distinct pericellular matrix that can potentiate cell-matrix communication and promote an NP-like phenotype.
Lastly, the ability of these mature hMSC-laden CMC constructs to achieve an NP-like phenotype was further indicated by the absence of COL I, 93 ,94 a fibroblastic marker, as well as COL X 94 and Alizarin Red staining, characteristic of hypertrophy and mineralization, respectively (Supplemental Figure S3) . 60 
Functional construct properties: Hydrogel swelling and mechanics
The measured functional properties of the cell-laden CMC hydrogels were directly impacted by the matrix elaboration profiles of the respective constructs. The accumulation of a dense network of matrix molecules seen by day 35 in both hydrogel groups reduced their swelling capacity. This was demonstrated by the reduction in the Q w of the hydrogels at both seeding densities, which by day 35 reached values comparable to that seen in native bovine NP tissue ($20) . 18 Consistent with our hypothesis, the equilibrium Young's modulus (E y ) of the 40 M group was significantly higher than the 20 M samples. The E y of both 20 M and 40 M groups by day 35 ($18 kPa and $28 kPa, respectively) were of the same order as other injectable hydrogels being studied for this application 22, 27, 65 (2-25 kPa) but exceeded reported values for native human NP ($5 kPa). 95 Nevertheless, this result may be beneficial in the harsh in vivo environment associated with IVD degeneration, in which polymer degradation may be more severe than under in vitro conditions. 59 The decrease in e eq and increase in r pk can be attributed to the newly deposited ECM in both groups. At day 35, the r pk values in both groups were significantly higher than at earlier time points, but cellseeding density did not have an effect on this transient mechanical response. The percent relaxation values remained relatively constant ($59%) in both groups over time and were comparable to numbers previously described for the native NP ($65%). 95 Additionally, a strong correlation was found between COL II and GAGs, and the E y in both cell density groups, suggesting that the accumulation of both ECM molecules equally contribute to the stiffness of the hydrogels (Supplemental Figure S4) . Although the focus of this study was on developing materials for eventual use in NP restoration, the CMC hydrogels could also potentially be utilized for articular cartilage repair by tuning the material properties to attain a higher compressive modulus and to produce an ECM profile with greater COL II relative to GAG content by encapsulated MSCs.
Conclusions
Overall, this is the first study to demonstrate the utility of injectable, redox-polymerized CMC hydrogels as suitable hMSC carriers for potential use in minimally invasive NP replacement and repair strategies. Interestingly, the cell-seeding density impacted the rate of COL II and GAG production differently, which contrary to our hypothesis, suggests that the rate of construct maturation does not depend solely on seeding density, and varies with the type of ECM macromolecule elaborated. While the 40 M gels were capable of producing higher quantities of GAG, the density of 20 Â 10 6 cells/ml can provide a more homogeneous matrix with a composition and mechanical properties similar to that of native NP. Therefore, future in vivo studies using redox-initiated crosslinking to form CMC hydrogels in a clinically relevant IVD injury model will employ the lower seeding density, and incorporate a growth factor delivery system to enhance the production of matrix molecules within the hydrogels to achieve native NP values and restore disc function.
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